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Objective. To investigate the contribution of Pelvic Organ Prolapse (POP) to micturition and defecation symptoms. Method.
Cross-sectional study including 64 women presenting with POP symptoms and 50 controls without POP complaints. Subjects
were evaluated using POP-Quantification system, Urinary Distress Inventory, and Defecation Distress Inventory. The MOS SF-36
health survey and the Center for Epidemiological Studies Depression scale were used to measure self-perceived health status and
depressive symptoms, respectively. Results. POP in terms of POP-Q had a moderate impact on the symptom observing vaginal
protrusion (explained variance 0.31). It contributed modestly to obstructive voiding and overactive bladder symptoms (explained
variance 0.09, resp., 0.14) but not to urinary incontinence. Constipation was more likely explained by clinical depression than by
pelvic floor defects (explained variance 0.13, resp., 0.05). Conclusion. Stage of POP and specific prolapse symptoms are associated
but such a strong association does not exist between POP and micturition or defecation symptoms.
1. Introduction
Pelvic organ prolapse (POP) is a common disorder often
associated with symptoms such as a vaginal bulging, pelvic
heaviness, bothersome micturition, and defecation symp-
toms as well as sexual dysfunction, often with a negative
impact on quality of life [1, 2]. It is unclear whether
the anatomical position of the bladder, bowel, and uterus
compromises the bladder and bowel function directly, or
whether abnormal anatomy and dysfunction of the pelvic
floor share a common etiology. Moreover, it is unclear
to what extent micturition and defecation symptoms can
be explained by the presence and degree of anatomical
abnormalities involved in POP. With the exception of vaginal
bulging, none of these symptoms are specific to vaginal
prolapse since they also exist in women without POP [3].
Whether or not the symptoms are related to POP is critical
to patient management. POP patients in whom defecation
symptoms dominate might be primarily referred to the
gastroenterologist, but if these patients present with a vaginal
prolapse, these patients are usually referred to the gyne-
cologist. The latter commonly offers POP surgery with the
correction of the anatomy as well as restoration of the pelvic
floor function as treatment aims. This treatment policy
assumes a causal rather than indirect relation between POP
and these symptoms. However, surgical results frequently
are disappointing in terms of pelvic floor function and
symptoms [4, 5].
In this study we address the unclear relation between
POP and pelvic floor symptoms and compare women who
present with symptomatic POP with asymptomatic women.
We investigated to what extent bladder and bowel symptoms
are related to specific anatomical defects of the pelvic floor
or to other factors like patient characteristics (e.g., age,
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parity, body weight, educational level) and psychological
characteristics.
2. Material and Methods
We conducted a cross-sectional study between January 2000
and January 2002 consisting of two groups. The study group
consisted of 64 women with symptomatic POP stage 2 or
more treated at the gynecology outpatient clinic of the
Onze Lieve Vrouwe Hospital. These patients participated in
a larger study on the evaluation of the diagnostic work-
up of patients with symptomatic primary POP [6–8]. The
control group consisted of 35 women who were referred to
the gynecology outpatient clinic for other complaints but
not seeking medical care for POP and 15 women without
gynecological complaints and who were not referred.
Exclusion criteria for both groups were being less than
6 months postpartum, having congenital defects of the
urogenital and/or gastrointestinal tract, a fibroid uterus with
a size ofmore than 12 weeks of pregnancy, large ovarian cysts,
prolapse surgery and/or hysterectomy in medical history,
a poor general condition precluding surgical therapy or
insufficient Dutch language proficiency. Patients who visited
the general gynecologic outpatient clinic were excluded from
the control group if they appeared to have symptoms of
pelvic prolapse.
The study was approved by the Medical Ethical Board of
the Onze Lieve Vrouwe Hospital.
Standardized medical review and physical examination
were carried out during the first visit at the gynecology
outpatient clinic of the Onze Lieve Vrouwe Hospital. Stage
of POP was assessed using the POP-Quantification (POP-
Q) system with the patient sitting 45 degrees upright in a
gynecological examination chair while she was instructed
to strain forcefully [9]. In agreement with the study of
Kahn and colleagues, we used the sum of the anatomic
landmarks genital hiatus (gh) and perineal body (pb) as
measure for perineal descent [10]. All pelvic examinations
were performed by the first author (A. G. Groenendijk).
In addition to a standard history review, each patient was
invited to complete the following surveys. (1) The MOS SF-
36 generic health-related quality-of-life questionnaire was
used to measure self-perceived health status [11]. We used
the overall physical andmental health summary scores (score
range: 0–100, a higher score indicates better health) as
indicators of physical and mental health. (2) The Center
for Epidemiological Studies Depression scale (CES-D) was
used to measure depressive symptoms [12] (scores range: 0
(no symptoms)−60(maximal symptoms); a cutoff score of
16 indicates clinical depression). (3) For the measurement
of urogenital and bowel symptoms and symptom-related
bother, we used two disease-specific symptom question-
naires. Firstly, the 19-item urinary distress inventory (UDI)
consists of five domains: genital prolapse (e.g., feeling and/or
seeing a vaginal bulge), urinary incontinence (e.g., urine
leakage related to physical activity, coughing, or sneezing and
urine leakage related to the feeling of urgency), overactive
bladder (e.g., frequency, urgency, and nocturia), obstructive
micturition (e.g., feeling of incomplete bladder emptying
and difficulties to empty the bladder), and discomfort/pain
(e.g., lower abdominal pressure, pain or discomfort lower
abdomen, push on the vaginal wall to have bowel move-
ment). Secondly, we used the 15-item defecation distress
inventory (DDI) consisting of four domains: constipation,
fecal incontinence, painful defecation, and incontinence for
gas. The constipation domain was covered by the following
items: less than 3 bowel movements a week, in 25% of
the time straining at defecation, feeling of incomplete
evacuation, sensation of anal blockage, and difficulties with
emptying the rectum (manual removal of feces out of the
rectum or push on the vaginal wall). Each domain score
ranges from 0 to 100, and a higher score indicates more
bother of reported symptoms [13, 14]. Both questionnaires
have been validated in the Dutch language.
3. Analysis
Differences in stage of pelvic organ prolapse, patient char-
acteristics, and reported pelvic floor symptoms between the
study and the control group were evaluated using the Stu-
dent’s independent samples t-test for Gaussian distributed
variables, the nonparametric Mann-Whitney U-test for
skewed variables, and the chi-square test for nominal/ordinal
variables.
The impact of (1) individual risk factors (age, body mass
index (BMI), parity, perineal trauma, summary physical
health (as proxy for comorbidity), and educational level),
alongside (2) specific pelvic floor defects (anterior, middle,
and posterior compartment defects) and (3) psychological
health status (clinical depression and summary mental
health) on the UDI and DDI domain scores (both log
transformed) was assessed using multiple linear regression
analysis. The resulting beta-coefficients represent the impact
on the log UDI or log DDI domain score when the risk
factor is changed with one unit of measurement. Adjusted
R2 was used as measure of model fit. The change in
adjusted R2 was used to quantify the contribution of patient
characteristics, psychological health, and specific pelvic floor
defects, respectively (in this order, stepwise multiple linear
regression analysis).
The post hoc sample size estimation showed that at
least 84 patients had to be included in the analysis (power
80%) or alternatively 111 patients (power 90%) (type I error
(alpha) = 0.05 (two sided), 13 predictors (see Table 2), effect
size = 0.25 corresponding to R2 = 0.20).
SPPS for Windows version 16.0 was used for data
management and statistical analysis. A two-sided P value
<0.05 was considered a statistically significant difference.
4. Results
Table 1 depicts the characteristics of the 64 women of the
study and the 50 women of the control group. Women in the
study group were on average older and had higher parity as
compared to the control group. Patients in the study group
on average had higher POP stage compared to the control
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Table 1: Patient’s characteristics.
Characteristics Study group (n = 64) Control group (n = 50) P value
Age (years), mean (SD) [range] 56.1 (10.4) [35–77] 48.9 (8.1) [37–72] <0.01
Body Mass Index (BMI), mean (SD) [range]a 25.38 (4.3) [18.4–39.1] 24.0 (4.3) [18.4–41.3] 0.99
Educational level 0.68
Primary school/lower vocational education 22 (34%) 6 (12%)
Secondary school/high school 21 (33%) 23 (46%)
Academic/university 22 (34%) 21 (42%)
Parity 0.04
0 0 (—) 4 (8%)
1 15 (23%) 21 (42%)
2 22 (35%) 16 (32%)
3 15 (23%) 8 (16%)
≥4 12 (19%) 1 (2%)
Overall, mean 2.3 1.6
Type of delivery 0.36
Vaginal delivery, no forceps or vacuum 56 (88%) 40 (80%)
Forceps and/or vacuum 8 (12%) 9 (18%)
Caesarian section only 0 (—) 1 (2%)
Perineal trauma (per patient) 0.52
No perineal trauma 16 (25%) 16 (32%)
Episiotomy or rupture 48 (75%) 34 (68%)
POP-Q points, mean (SD)b
Aa −0.8 (1.1) −2.0 (1.2)
Ba 2.2 (2.2) −1.9 (1.3)
C −0.2 (4.1) −5.7 (1.4)
Gh 4.1 (1.1) 2.2 (0.7)
Pb 2.7 (0.7) 2.9 (0.6)
Ap 0.2 (1.4) −1.6 (1.5)
Bp 0.3 (1.6) −1.5 (1.5)
TVL 8.1 (1.1) 8.6 (1.1)
POP-Q stage <0.01
Stage I 0 (—) 24 (48%)
Stage II 17 (27%) 24 (48%)
Stage III 42 (66%) 2 (4%)
Stage IV 5 (8%) 0 (—)
UDI domains, median (IQR)
Prolapse symptoms 33.3 (45.8) 0.0 (0.0) <0.01
Obstructed voiding 16.7 (33.3) 0.0 (0.0) <0.01
Overactive bladder 27.8 (30.6) 0.0 (22.2) <0.01
Discomfort and pain 22.2 (31.9) 5.6 (16.7) <0.01
Urinary incontinence 13.3 (26.7) 6.6 (13.3) <0.01
UDI total 127.8 (69.1) 22.2 (35.0) <0.01
DDI domains, median (IQR)
Constipation 4.7 (17.3) 0.0 (9.5) 0.08
Fecal incontinence 0.0 (13.3) 0.0 (0.0) 0.02
Painful defecation 0.0 (0.0) 0.0 (0.0) 0.64
Flatus incontinence 16.7 (41.7) 0.0 (33.3) 0.02
DDI total 34.5 (67.4) 21.0 (45.4) 0.03
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Table 1: Continued.
Characteristics Study group (n = 64) Control group (n = 50) P value
General health (MOS SF36), mean (SD)
Summary mental health 46.3 (14.6) 50.3 (15.0) 0.42
Summary physical health 48.5 (11.3) 54.3 (11.7) <0.01
Depression (CES-D)
Clinical depressionc 23 (36%) 13 (26%) 0.52
BMI: body mass index; IQR: interquartile range; SD: standard deviation.
aBMI of women in the normal population is 18–24 (body mass index = kg/m2).
bPoint D was not correctly measured in all case and was excluded from the study.
cDefined as a CES-D score ≥16.
group (POP III/IV: 74% versus 4%, resp.), and their physical
health was significantly worse.
The study group reported significantly more bother
from urogenital and bowel symptoms. Significant differences
between the groups were found for all UDI domains as well
as the flatus and fecal incontinence domains of the DDI.
Feeling of vaginal protrusion (50/64 (78%)) and overactive
bladder symptoms (45/64 (70%)) were the most frequent
and bothersome symptoms in the study group followed by
complaints of discomfort and pain. In the control group,
the most prevalent and bothersome complaint was urinary
incontinence (22/50, 44%). Frequently reported defecation
symptoms in both groups were false urge for defecation
(27/64 (42%) and 17/50 (34%), resp.), obstructed defecation
(29/64 (45%) and 12/50 (24%)), and feeling of incomplete
defection (29/64 (45%) and 8/50 (16%), resp.).
Table 2 shows the association between micturition (UDI)
and defecation (DDI) scores on the one hand and patient’s
characteristics, POP-Q scores, and psychological characteris-
tics on the other.
4.1. Prolapse Feeling. Pelvic floor defects, dominated by
anterior vaginal wall prolapse (Ba) and perineal descent of
the pelvic floor (gh + pb), accounted for 31% (P < 0.001)
of the variance in symptom scores. The impact of clinical
depression and summary mental health on prolapse feeling
was small (variance explained: 2%, P = 0.14). Patient
characteristics overall explained 14%. A higher BMI adjusted
for other covariables was associated with lower scores of
prolapse feeling.
4.2. Obstructive Voiding. Voiding problems were associated
to specific pelvic floor defects but the overall contribution
was modest (9% of explained variance, P = 0.004).
Voiding problems were predominantly related to patient
characteristics, explaining 21% of variance (P < 0.001).
The relationship between presence of perineal trauma and
voiding obstruction was inverse. Patients with better overall
physical health had significantly less bother from voiding
obstruction, but the impact was small.
4.3. Overactive Bladder. Overactive bladder symptoms were
mainly related to pelvic floor defects (14% of variance
explained, P = 0.001), especially to posterior vaginal wall
prolapse (point Bp) and to a lesser extent point C. The
contribution of patient characteristics was small (7% of
variance explained). Only educational level had a significant
impact on overactive bladder symptoms, that is, women with
lower vocational education had more bother of overactive
bladder symptoms.
4.4. Discomfort and Pain. Discomfort and pain were mainly
related to pelvic floor defects (12% of variance explained),
especially posterior vaginal wall prolapse (Bp) and perineal
descent of the pelvic floor (gh + pb). However, discomfort
and pain scores were also partially explained by patient
and psychological characteristics; patients with lower overall
physical health and clinically depressed patient showed more
discomfort and pain.
4.5. Constipation. Constipation was predominantly related
to psychological factors (13% of variance explained). Par-
ticularly clinically depressed patients reported higher levels
of constipation. Constipation was to a lesser extent also
related to pelvic floor defects (5% of variance explained,
P = 0.033); particularly perineal descent (gh + pb) had
a significant impact on constipation (P = 0.03). Of the
patient characteristics only BMI and physical health were
significantly related to constipation.
4.6. Other UDI and DDI Domains. None of the covariables
studied had a significant impact on urinary incontinence
(UDI) and fecal incontinence, painful defecation, and incon-
tinence for gas (DDI).
We also examined the association of mild or more severe
prolapse with urinary incontinence. In the mild prolapse
group (overall POP-Q stages I and II; n = 65), the impact of
anterior wall prolapse (represented by point Ba) on the UDI
domain score (log transformed) with the same predictors as
in Table 2 was beta = 2.75, 95%-CI: 0.04 to 1.25 (P < 0.01).
In the severe prolapse group (overall POP-Q stages III and
IV; n = 49) we found an inverse but not significant impact of
anterior wall prolapse on urinary incontinence: beta=−0.18,
95%-CI: −0.51 to 0.16 (P = 0.28).
5. Discussion
In this study the association between anatomical and func-
tional abnormalities of the pelvic floor was poor. Anatomical
defects and, to a lesser extent, patient characteristics were
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Table 2: Multiple linear regression analysis showing the relationship between patient’s characteristics, psychological characteristics and
anatomical defects at the one hand and pelvic floor symptoms (log scale) at the other hand.
β-coefficient [95%-CI] P value Change in R2 adjusted (P value of change)
(i) UDI-prolapse feeling (log scale)
Constant 3.28 [−7.17 to 7.29] 0.11
Patient characteristics 0.14 (P < 0.01)
Age (years) 0.00 [−0.03 to 0.04] 0.80
BMI −1.00 [−0.17 to −0.3] <0.01
Parity 0.14 [−0.08 to 0.36] 0.22
Perineal trauma −0.19 [−0.80 to 0.42] 0.54
Physical health −0.02 [−1.13 to 0.25] 0.28
Educational level 1a −0.20 [−0.73 to 0.72] 0.96
Educational level 2b −0.44 [−1.13 to 0.25] 0.21
Psychological factors 0.02 (P = 0.14)
Clinical depression 0.65 [−0.02 to 1.32] 0.06
Mental health −0.01 [−0.04 to 0.02] 0.7
POP-Q points 0.31 (P < 0.01)
Ba 0.22 [0.04 to 0.39] 0.01
C 0.04 [−0.07 to 0.15] 0.51
Bp 0.17 [−0.02 to 0.36] 0.07
gh + pb 0.31 [0.05 to 0.58] 0.02
Full model 0.47 (P < 0.01)
(ii) UDI-obstructive voiding (log scale)
Constant 4.69 [0.74 to 8.64] 0.02
Patient characteristics 0.21 (P < 0.01)
Age (years) −0.01 [−0.05 to 0.02] 0.44
BMI 0.02 [−0.05 to 0.09] 0.55
Parity 0.16 [−0.07 to 0.38] 0.17
Perineal trauma −0.95 [−1.56 to−0.35] <0.01
Physical health −0.06 [−0.09 to −0.02] <0.01
Educational level 1a 0.44 [−0.30 to 1.17] 0.24
Educational level 2b −0.22 [−0.91 to 0.46] 0.52
Psychological factors 0.00 (P = 0.35)
Clinical depression −0.35 [−1.01 to 0.32] 0.30
Mental health −0.02 [−0.05 to 0.01] 0.24
POP-Q points 0.09 (P < 0.01)
Ba −0.03 [−0.20 to 0.14] 0.71
C 0.10 [−0.00 to 0.21] 0.06
Bp 0.09 [−0.09 to 0.28] 0.33
gh + pb 0.18 [−0.09 to 0.44] 0.18
Full model 0.30 (P < 0.01)
(iii) UDI-overactive bladder (log scale)
Constant 3.09 [−0.91 to 7.09] 0.13
Patient characteristics 0.07 (P = 0.04)
Age (years) 0.00 [−0.04 to 0.04] 0.99
BMI −0.01 [−0.08 to 0.06] 0.85
Parity −0.03 [−0.26 to 0.19] 0.77
Perineal trauma −0.33 [−0.94 to 0.28] 0.28
Physical health 0.01 [−0.03 to 0.04] 0.67
Educational level 1a −0.98 [−1.72 to −0.24] 0.01
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Table 2: Continued.
β-coefficient [95%-CI] P value Change in R2 adjusted (P value of change)
Educational level 2b −0.54 [−1.23 to 0.16] 0.13
Psychological factors 0.00 (P = 0.49)
Clinical depression 0.27 [−0.40 to 0.94] 0.43
Mental health 0.001 [−0.03 to 0.03] 0.97
POP-Q points 0.14 (P < 0.01)
Ba −0.02 [−0.15 to 0.19] 0.80
C 0.11 [−0.00 to 0.21] 0.06
Bp 0.24 [ 0.06 to 0.43] 0.01
gh + pb −0.01 [−0.27 to 0.26] 0.97
Full model 0.21 (P < 0.01)
(iv) UDI-discomfort and pain (log scale)
Constant 4.93 [0.88 to 7.91] 0.01
Patient characteristics 0.10 (P = 0.01)
Age (years) −0.01 [0.05 to 0.02] 0.36
BMI −0.04 [−0.11 to 0.03] 0.25
Parity 0.09 [−0.11 to 0.29] 0.36
Perineal trauma 0.19 [−0.35 to 0.72] 0.49
Physical health −0.04 [−0.07 to−0.01] 0.02
Educational level 1a −0.09 [−0.74 to 0.57] 0.79
Educational level 2b −0.18 [−0.79 to 0.43] 0.56
Psychological factors 0.07 (P < 0.01)
Clinical depression 0.73 [0.14 to1.32] 0.02
Mental health −0.01 [−0.04 to 0.01] 0.37
POP-Q points 0.12 (P < 0.01)
Ba −0.02 [−0.17 to 0.13] 0.79
C 0.05 [−0.05 to 0.14] 0.35
Bp 0.17 [0.00 to 0.33] 0.05
gh + pb 0.24 [0.00 to 0.47] 0.05
Full model 0.29 (P < 0.01)
(v) DDI-constipation (log scale)
Constant 3.32 [−0.08 to 6.71] 0.06
Patient characteristics 0.06 (P = 0.07)
Age (years) 0.00 [−0.03 to 0.03] 0.99
BMI −0.08 [−0.14 to −0.02] 0.01
Parity 0.09 [−0.10 to 0.28] 0.35
Perineal trauma −0.12 [−0.64 to 0.40] 0.69
Physical health −0.03 [−0.06 to−0.01] 0.02
Educational level 1a 0.58 [−0.31 to 0.87] 0.69
Educational level 2b 0.28 [−0.31 to 0.87] 0.07
Psychological factors 0.13 (P < 0.01)
Clinical depression 0.96 [0.39 to1.53] <0.01
Mental health −0.01 [−0.04 to 0.01] 0.35
POP-Q points 0.05 (P = 0.03)
Ba −0.02 [−0.16 to 0.13] 0.82
C −0.08 [−0.17 to 0.02] 0.10
Bp 0.12 [−0.04 to 0.28] 0.16
gh + pb 0.26 [0.03 to 0.49] 0.03
Full model 0.24 (P < 0.01)
a
Secondary education; reference is primary school/lower vocational education.
bHigher professional education; reference is primary school/lower vocational education.
Obstetrics and Gynecology International 7
associated with obstructive voiding and overactive bladder
but not with urinary incontinence. Any direct association
between psychological factors and micturition symptoms
appeared absent. Defecation symptoms were unrelated to
anatomical abnormalities, patient characteristics, or psycho-
logical factors, except for constipation which was associated
with psychological factors and, to a lesser extent, with
perineal descent. Since the explanatory power of all pelvic
floor symptoms was small, it is still unclear which are
the main factors that underlie micturition and defecation
symptoms.
Some limitations of this study need to be discussed.
Firstly, although in agreement with other studies, only few
of our patients presented with severe posterior compart-
ment prolapse. As our study group represents an average
distribution of vaginal prolapse patients, we do not believe
this to be an important drawback. An overrepresentation
of patients with severe posterior wall defects is likely to
strengthen the relationship between posterior defects and
defecation symptoms. Furthermore, forty percent of the
women in the control group had a prolapse stage II according
to the POP-Q classification system. This high prevalence
of mild prolapse is in agreement with epidemiological
studies that showed that up to 40% of women over the
age of fifty years have mild asymptomatic prolapse [15, 16],
which we regard as still a physiologic condition. Secondly,
we did not document whether patients or controls had
comorbidity. Instead, we used the SF-36 summary physical
health dimension as a proxy measure. Probably, this is
a more valuable measure to investigate whether pelvic
floor function is associated with patient’s general health
status. Thirdly, since patients and controls had different
characteristics, we adjusted for the documented prognostic
factors in the multiple regression analysis. We do not think
that prognostic incomparability plays an important role as
all theoretical prognostic factors were documented in both
groups.
Finally, there are two statistical limitations. We did not
adjust the type I error level formultiple testing. Furthermore,
regression analyses with multiple variables may have intro-
duced multicollinearity or confounding. Multicollinearity
did not occur as all bivariate correlations between covariables
were <0.80. Removal of the POP-Q points from the regres-
sion model showed significant associations between parity
and prolapse feeling (beta = 0.4, P = 0.003) and between
age and fecal incontinence (beta = 0.04, P = 0.01). Although
associations between covariables might affect the significance
of the beta coefficients, they generally do not affect the R2 of
the model.
Although POP and urinary incontinence frequently
coincided, we found no significant relationship between
prolapse and overall urinary incontinence symptoms. An
explanation could be that mild prolapse is associated with
urinary stress incontinence but severe prolapse is more
associated with continence and voiding dysfunction. This
theory is supported by our findings from the stratified
analysis, showing that mild anterior wall prolapse was found
to be significantly associated with urinary incontinence but
severe anterior wall prolapse was not.
Furthermore, posterior compartment prolapse was asso-
ciated with overactive bladder symptoms whereas, in con-
trast to what one may expect, anterior wall compartment
prolapse was not. Only few studies on the relationship
between POP and these symptoms are available. Some
researchers found a relationship between anterior wall
prolapse and overactive bladder symptoms due to outlet
obstruction of the bladder [17], while others could not
corroborate that association [18]. Our findings are in
agreement with the findings of other reports that show that
the site of POP and the type of pelvic floor symptoms are not
consistently related [19, 20].
Experienced discomfort and pain in the pelvic area
appeared to be related to clinical depression but from
this study we cannot conclude whether this is a causal
relationship or not. Furthermore we found that discomfort
and pain symptoms were strongly related to posterior vaginal
wall prolaps and perineal descent than to anterior vaginal
wall prolapse. Maybe the feeling of pressure on the pelvic
floor is caused by invisible structural abnormalities of the
posterior compartment like enterocele [21, 22].
Surprisingly, we found no significant effect of age and
parity on urogenital and defecation symptoms. One reason
may be that the variation of these factors in our population
was small, hampering the detection of significant associa-
tions. Alternatively, age and parity may have been undetected
due to their associations with the respective POPQ points.
Furthermore, we found that a higher BMI was inversely
related to prolapse feeling. While the literature supports
overweight as a risk factor for pelvic organ prolapse [23],
other studies show a protective effect of higher BMI level on
pelvic floor injury [24, 25].
Defecation symptoms are frequently reported by women
with POP [26] but whether they are the cause or the result
of POP is unclear. Researchers report conflicting results
about the relationship between the severity of prolapse
and bowel symptoms [27, 28]. The association between
pelvic floor defects and defecation symptoms in our study
appeared to be small to absent. One explanation is that
other factors than POP are predominantly responsible for
defecation symptoms. The multifactorial pathophysiology
of defecation disorders is likely to reduce the contribution
of POP, that is, posterior vaginal wall prolapse amongst
other factors, for example, occult anorectal anomalies, pelvic
floor dyssynergia, endocrine and metabolic factors, and use
of medication. The DDI we used to assess the presence
of constipation is not valid to determine the symptom’s
etiology. While outlet obstruction seems responsible for
the association between perineal descent and constipation,
the association between clinical depression and constipation
points to slow transit constipation as the result of different
life style.
Another explanation could be that small and mild pos-
terior wall prolapses as frequently found in our study group
should be regarded a physiologic condition often present in
women without defecation complaints [29] but too small to
cause outlet obstruction. Finally, one may question whether
POP-Q scores are the best representation of abnormalities
of the rectovaginal wall [7, 30] since imaging techniques
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(defecography, MRI) can reveal anatomical abnormalities
of the posterior compartment that are not represented by
abnormal POP-Q scores [31].
Although POP and prolapse symptoms are associated,
in our study we did not find a strong relationship between
the affected compartment and most of the micturition and
defecation symptoms.
An explanation would be that prolapse and pelvic floor
symptoms share a common aetiology rather than they have
a direct causal relationship. Pathophysiologic concepts that
might relate to prolapse and pelvic floor symptoms are
collagen disease, abnormally weak pelvic floor muscles due
to childbirth and pelvic floor neuropathy [32, 33]. The same
neuropathy can obviously cause prolapse and a full range of
bladder and bowel symptoms.
The above findings may have important clinical impli-
cations. In patients with mild POP who are not bothered
by prolapse symptoms, surgical repair as treatment for
functional disorders seems ill founded. In such cases, we
first recommend conservative management of pelvic floor
symptoms. Second, patients scheduled for POP surgery
should be informed that coexisting micturition and defe-
cation symptoms are not necessarily the result of POP
and these may persist after surgery. The low proportion of
explained variation in micturition and defecation symptoms
stress the urge to further explore which factors determine the
high prevalence of micturition and defecation symptoms in
patients who present with POP. Improved insight into these
factors may help to optimize the diagnostic work-up and
treatment setting in patients with pelvic floor dysfunction.
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